Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA) ; volume:21 ; number:1 ; day:10 ; month:2 ; year:2020 ; pages:1-10 ; date:12.2020
Trials ; 21, Heft 1 (10.2.2020), 1-10, 12.2020
- Urheber
-
Mulder, Michelle L. M.
Vriezekolk, Johanna E.
Broeder, Nathan den
Mahler, Elien A. M.
Helliwell, Philip S.
Hoogen, Frank H. J. van den
Broeder, Alfons A. den
Wenink, Mark H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-020-4097-6
- URN
-
urn:nbn:de:101:1-2020051014162882784012
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mulder, Michelle L. M.
- Vriezekolk, Johanna E.
- Broeder, Nathan den
- Mahler, Elien A. M.
- Helliwell, Philip S.
- Hoogen, Frank H. J. van den
- Broeder, Alfons A. den
- Wenink, Mark H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial
Methotrexate
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Potential neurotoxicity associated with methotrexate
Methotrexate intolerance in Rheumatoid Arthritis
The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Methotrexate-Related Pancytopenia: A Case Report
Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial
Methotrexate
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Potential neurotoxicity associated with methotrexate
Methotrexate intolerance in Rheumatoid Arthritis
The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Methotrexate-Related Pancytopenia: A Case Report
Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial
Methotrexate
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Potential neurotoxicity associated with methotrexate
Methotrexate intolerance in Rheumatoid Arthritis
The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan